APO RESEARCH · REPORT
10% Dextrose Injection
10% Dextrose Injection is a packaged medical solution or multi-compartment preparation supplied for an identified parenteral-use specification.
Product & engineering
Understand the product.
Composition, compartment arrangement, container integrity and labelled use distinguish the product. Mixing compatibility, clinical selection and administration are separate product-specific requirements.
The commercial boundary
The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.
Which composition and container configuration define the preparation?
Composition, compartment arrangement, container integrity and labelled use distinguish the product. Mixing compatibility, clinical selection and administration are separate product-specific requirements.
Selected research
Industry Research
10% Dextrose Injection Industry Research Report 2026
Market perspective
The global 10% Dextrose Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 10% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 10% Dextrose Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 10% Dextrose Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 10% Dextrose Injection include Pfizer, Fresenius Kabi, Baxter, Schwitz Biotech, Otsuka Pharmaceutical, ICU Medical, Drugfield Pharmaceuticals Limited, B. Braun Medical Inc and Alfa Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 10% Dextrose Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
10% Dextrose Injection Market by Company
Pfizer
Fresenius Kabi
Baxter
Schwitz Biotech
Otsuka Pharmaceutical
ICU Medical
Drugfield Pharmaceuticals Limited
B. Braun Medical Inc
Alfa Laboratories
10% Dextrose Injection Segment by Type
1000 mL
250 mL
500 mL
10% Dextrose Injection Segment by Application
Trophotherapy
Sports
First-Aid Treatment
Others
10% Dextrose Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10% Dextrose Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 10% Dextrose Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10% Dextrose Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 10% Dextrose Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 10% Dextrose Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 10% Dextrose Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1000 mL
- 250 mL
- 500 mL
Applications
- Trophotherapy
- Sports
- First-Aid Treatment
- Others
Companies covered
- Pfizer
- Fresenius Kabi
- Baxter
- Schwitz Biotech
- Otsuka Pharmaceutical
- ICU Medical
- Drugfield Pharmaceuticals Limited
- B. Braun Medical Inc
- Alfa Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global 10% Dextrose Injection Market Size (2021-2032)
- 2.2.2 Global 10% Dextrose Injection Sales (2021-2032)
- 2.2.3 Global 10% Dextrose Injection Market Average Price (2021-2032)
- 2.3 10% Dextrose Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1000 mL
- 2.3.3 250 mL
- 2.3.4 500 mL
- 2.4 10% Dextrose Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Trophotherapy
- 2.4.3 Sports
- 2.4.4 First-Aid Treatment
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 10% Dextrose Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global 10% Dextrose Injection Sales (K L) of Manufacturers (2021-2026)
- 3.3 Global 10% Dextrose Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global 10% Dextrose Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global 10% Dextrose Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of 10% Dextrose Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of 10% Dextrose Injection, Product Type & Application
- 3.8 Global Manufacturers of 10% Dextrose Injection, Established Date
- 3.9 Global 10% Dextrose Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer 10% Dextrose Injection Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Fresenius Kabi
- 4.2.1 Fresenius Kabi Company Information
- 4.2.2 Fresenius Kabi Business Overview
- 4.2.3 Fresenius Kabi 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Kabi 10% Dextrose Injection Product Portfolio
- 4.2.5 Fresenius Kabi Recent Developments
- 4.3 Baxter
- 4.3.1 Baxter Company Information
- 4.3.2 Baxter Business Overview
- 4.3.3 Baxter 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter 10% Dextrose Injection Product Portfolio
- 4.3.5 Baxter Recent Developments
- 4.4 Schwitz Biotech
- 4.4.1 Schwitz Biotech Company Information
- 4.4.2 Schwitz Biotech Business Overview
- 4.4.3 Schwitz Biotech 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Schwitz Biotech 10% Dextrose Injection Product Portfolio
- 4.4.5 Schwitz Biotech Recent Developments
- 4.5 Otsuka Pharmaceutical
- 4.5.1 Otsuka Pharmaceutical Company Information
- 4.5.2 Otsuka Pharmaceutical Business Overview
- 4.5.3 Otsuka Pharmaceutical 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Otsuka Pharmaceutical 10% Dextrose Injection Product Portfolio
- 4.5.5 Otsuka Pharmaceutical Recent Developments
- 4.6 ICU Medical
- 4.6.1 ICU Medical Company Information
- 4.6.2 ICU Medical Business Overview
- 4.6.3 ICU Medical 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ICU Medical 10% Dextrose Injection Product Portfolio
- 4.6.5 ICU Medical Recent Developments
- 4.7 Drugfield Pharmaceuticals Limited
- 4.7.1 Drugfield Pharmaceuticals Limited Company Information
- 4.7.2 Drugfield Pharmaceuticals Limited Business Overview
- 4.7.3 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Product Portfolio
- 4.7.5 Drugfield Pharmaceuticals Limited Recent Developments
- 4.8 B. Braun Medical Inc
- 4.8.1 B. Braun Medical Inc Company Information
- 4.8.2 B. Braun Medical Inc Business Overview
- 4.8.3 B. Braun Medical Inc 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 B. Braun Medical Inc 10% Dextrose Injection Product Portfolio
- 4.8.5 B. Braun Medical Inc Recent Developments
- 4.9 Alfa Laboratories
- 4.9.1 Alfa Laboratories Company Information
- 4.9.2 Alfa Laboratories Business Overview
- 4.9.3 Alfa Laboratories 10% Dextrose Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alfa Laboratories 10% Dextrose Injection Product Portfolio
- 4.9.5 Alfa Laboratories Recent Developments
5 Global 10% Dextrose Injection Market Scenario by Region
- 5.1 Global 10% Dextrose Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global 10% Dextrose Injection Sales by Region: 2021-2032
- 5.2.1 Global 10% Dextrose Injection Sales by Region: 2021-2026
- 5.2.2 Global 10% Dextrose Injection Sales by Region: 2027-2032
- 5.3 Global 10% Dextrose Injection Revenue by Region: 2021-2032
- 5.3.1 Global 10% Dextrose Injection Revenue by Region: 2021-2026
- 5.3.2 Global 10% Dextrose Injection Revenue by Region: 2027-2032
- 5.4 North America 10% Dextrose Injection Market Facts & Figures by Country
- 5.4.1 North America 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America 10% Dextrose Injection Sales by Country (2021-2032)
- 5.4.3 North America 10% Dextrose Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe 10% Dextrose Injection Market Facts & Figures by Country
- 5.5.1 Europe 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe 10% Dextrose Injection Sales by Country (2021-2032)
- 5.5.3 Europe 10% Dextrose Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific 10% Dextrose Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific 10% Dextrose Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific 10% Dextrose Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America 10% Dextrose Injection Market Facts & Figures by Country
- 5.7.1 South America 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America 10% Dextrose Injection Sales by Country (2021-2032)
- 5.7.3 South America 10% Dextrose Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa 10% Dextrose Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa 10% Dextrose Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa 10% Dextrose Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa 10% Dextrose Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global 10% Dextrose Injection Sales by Type (2021-2032)
- 6.1.1 Global 10% Dextrose Injection Sales by Type (2021-2032) & (K L)
- 6.1.2 Global 10% Dextrose Injection Sales Market Share by Type (2021-2032)
- 6.2 Global 10% Dextrose Injection Revenue by Type (2021-2032)
- 6.2.1 Global 10% Dextrose Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global 10% Dextrose Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global 10% Dextrose Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global 10% Dextrose Injection Sales by Application (2021-2032)
- 7.1.1 Global 10% Dextrose Injection Sales by Application (2021-2032) & (K L)
- 7.1.2 Global 10% Dextrose Injection Sales Market Share by Application (2021-2032)
- 7.2 Global 10% Dextrose Injection Revenue by Application (2021-2032)
- 7.2.1 Global 10% Dextrose Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global 10% Dextrose Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global 10% Dextrose Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 10% Dextrose Injection Value Chain Analysis
- 8.1.1 10% Dextrose Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 10% Dextrose Injection Production Mode & Process
- 8.2 10% Dextrose Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 10% Dextrose Injection Distributors
- 8.2.3 10% Dextrose Injection Customers
9 Global 10% Dextrose Injection Analyzing Market Dynamics
- 9.1 10% Dextrose Injection Industry Trends
- 9.2 10% Dextrose Injection Industry Drivers
- 9.3 10% Dextrose Injection Industry Opportunities and Challenges
- 9.4 10% Dextrose Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst